nayan patel glutathione Revolution – Auro Wellness The Glutathione Revolution: Fight Disease,

Umeda R, Teranishi H, Hada K, Shimizu N, Shiraishi H, Urushibata H, et al

33 For young adults (age 2039), a 2018 expert panel recommended cholesterol-lowering therapy for those with LDL cholesterol over 160 mg/dL and a history of early-onset atherosclerosis in a close family member

This response was more limited to the gut, so may have helped more in people with gastrointestinal issues like irritable bowel syndrome and Crohns

Ozempic is a GLP-1 receptor agonist (semaglutide), while retatrutide targets GLP-1, GIP, and glucagon receptors

Funding This work was supported by the Shanghai Science and Technology Development Funds (No